Proton Pump Inhibitors PPIs Research 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Proton pump inhibitors and risk of bloodstream infection without an identifiable source: a hospital-based case-control study
In conclusion, PPI use is associated with higher risk of BSI without an identifiable source and therefore, PPI use may increase the risk of septic morbidity secondary to bacterial translocation.PMID:38296545 | DOI:10.7883/yoken.JJID.2023.253 (Source: Japanese Journal of Infectious Diseases)
Source: Japanese Journal of Infectious Diseases - January 31, 2024 Category: Infectious Diseases Authors: Shintaro Hayashi Tomohito Moriyama Yuichiro Ito Yuta Harada Hiroki Dodo Kana Kumahara Tatsuji Yogi Noritsugu Ohashi Reiji Higashi Akihiro Mori Source Type: research
Primary gastrinoma of the gallbladder: a case report and review of the literature
ConclusionsThis case confirmed that primary gallbladder gastrinoma represents a distinct nosological entity. Immunohistochemical analysis plays a pivotal role in the diagnostic process. Given the limited understanding of primary gallbladder gastrinoma, our objective is to offer novel insights into this rare disease by delivering distinctive information and highlighting the therapeutic significance of surgical intervention. (Source: Frontiers in Oncology)
Source: Frontiers in Oncology - January 31, 2024 Category: Cancer & Oncology Source Type: research
Comment on “Risk of gastric cancer among long‑term proton pump inhibitor users: a population‑based cohort study”
(Source: European Journal of Clinical Pharmacology)
Source: European Journal of Clinical Pharmacology - January 31, 2024 Category: Drugs & Pharmacology Source Type: research
Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients
ConclusionsThe optimal cutoff duration for PPI and H2RA use was about 2 weeks. It is necessary to be cautious regarding the risk of CDI in patients taking PPIs or H2RAs for longer than 2 weeks. (Source: Infectious Diseases and Therapy)
Source: Infectious Diseases and Therapy - January 30, 2024 Category: Infectious Diseases Source Type: research
